| Primary |
| Attention Deficit/hyperactivity Disorder |
50.0% |
| Product Used For Unknown Indication |
20.6% |
| Depression |
6.4% |
| Drug Use For Unknown Indication |
4.4% |
| Anxiety |
2.8% |
| Insomnia |
2.1% |
| Hypertension |
1.8% |
| Asthma |
1.3% |
| Seasonal Allergy |
1.3% |
| Sleep Disorder |
1.3% |
| Bipolar Disorder |
1.0% |
| Chronic Fatigue Syndrome |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Hypersensitivity |
1.0% |
| Hypothyroidism |
0.8% |
| Post-traumatic Stress Disorder |
0.8% |
| Supplementation Therapy |
0.8% |
| Affective Disorder |
0.5% |
| Autism |
0.5% |
| Back Pain |
0.5% |
|
| Weight Decreased |
15.0% |
| Suicidal Ideation |
11.0% |
| Off Label Use |
7.0% |
| Overdose |
7.0% |
| Product Substitution Issue |
7.0% |
| Tic |
5.0% |
| Convulsion |
4.0% |
| Depression |
4.0% |
| Drug Ineffective |
4.0% |
| Hallucination |
4.0% |
| Sudden Death |
4.0% |
| Tachycardia |
4.0% |
| Aggression |
3.0% |
| Cleft Palate |
3.0% |
| Mood Swings |
3.0% |
| Product Quality Issue |
3.0% |
| Suicide Attempt |
3.0% |
| Tremor |
3.0% |
| Unevaluable Event |
3.0% |
| Urticaria |
3.0% |
|
| Secondary |
| Attention Deficit/hyperactivity Disorder |
35.5% |
| Depression |
9.0% |
| Product Used For Unknown Indication |
7.8% |
| Anxiety |
7.0% |
| Drug Use For Unknown Indication |
5.9% |
| Bipolar Disorder |
4.7% |
| Insomnia |
4.7% |
| Sleep Disorder |
4.3% |
| Somnolence |
3.9% |
| Asthma |
3.5% |
| Hypertension |
3.5% |
| Obsessive-compulsive Disorder |
1.6% |
| Off Label Use |
1.6% |
| Affective Disorder |
1.2% |
| Fibromyalgia |
1.2% |
| Mineral Supplementation |
1.2% |
| Narcolepsy |
1.2% |
| Arthralgia |
0.8% |
| Asthenia |
0.8% |
| Barrett's Oesophagus |
0.8% |
|
| Drug Exposure During Pregnancy |
11.5% |
| Hallucination |
11.5% |
| Weight Decreased |
8.2% |
| Cerebrovascular Accident |
6.6% |
| Off Label Use |
6.6% |
| Urinary Incontinence |
6.6% |
| Mood Swings |
4.9% |
| Product Substitution Issue |
4.9% |
| Aggression |
3.3% |
| Anxiety |
3.3% |
| Drug Dispensing Error |
3.3% |
| Drug Effect Decreased |
3.3% |
| Fatigue |
3.3% |
| Hepatic Enzyme Increased |
3.3% |
| Hyperhidrosis |
3.3% |
| Inappropriate Schedule Of Drug Administration |
3.3% |
| Overdose |
3.3% |
| Pollakiuria |
3.3% |
| Product Quality Issue |
3.3% |
| Sarcoidosis |
3.3% |
|
| Concomitant |
| Attention Deficit/hyperactivity Disorder |
15.8% |
| Product Used For Unknown Indication |
14.6% |
| Depression |
11.2% |
| Contraception |
7.0% |
| Bipolar Disorder |
6.1% |
| Pain |
5.9% |
| Drug Use For Unknown Indication |
5.1% |
| Multiple Sclerosis |
5.1% |
| Anxiety |
3.9% |
| Acne |
3.4% |
| Premenstrual Syndrome |
3.0% |
| Hypertension |
2.8% |
| Headache |
2.3% |
| Arthritis |
2.1% |
| Crohn's Disease |
2.0% |
| Migraine |
2.0% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Hypersensitivity |
1.9% |
| Sleep Disorder |
1.9% |
| Smoking Cessation Therapy |
1.8% |
|
| Pulmonary Embolism |
8.4% |
| Weight Decreased |
8.4% |
| Weight Increased |
8.4% |
| Suicidal Ideation |
7.0% |
| Vomiting |
7.0% |
| Injury |
6.3% |
| Viral Pharyngitis |
5.6% |
| Nausea |
4.9% |
| Rash |
4.9% |
| Fatigue |
4.2% |
| Tremor |
4.2% |
| Drug Ineffective |
3.5% |
| Gallbladder Disorder |
3.5% |
| Insomnia |
3.5% |
| Multiple Sclerosis Relapse |
3.5% |
| Myalgia |
3.5% |
| Pain |
3.5% |
| Tic |
3.5% |
| White Blood Cell Count Decreased |
3.5% |
| Anxiety |
2.8% |
|
| Interacting |
| Attention Deficit/hyperactivity Disorder |
25.9% |
| Smoking Cessation Therapy |
18.5% |
| Disturbance In Attention |
14.8% |
| Anxiety |
7.4% |
| Ex-smoker |
7.4% |
| Ex-tobacco User |
7.4% |
| Pain |
7.4% |
| Affective Disorder |
3.7% |
| Depression |
3.7% |
| Muscle Spasms |
3.7% |
|
| Vomiting |
44.4% |
| Drug Interaction |
22.2% |
| Irritability |
11.1% |
| Therapeutic Response Unexpected |
11.1% |
| Tic |
11.1% |
|
